Jafron Biomedical Co.,Ltd. (300529.SZ)

CNY 30.04

(-0.07%)

Market Cap (In CNY)

23.61 Billion

Revenue (In CNY)

1.92 Billion

Net Income (In CNY)

436.49 Million

Avg. Volume

5.25 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
15.88-39.24
PE
-
EPS
-
Beta Value
0.359
ISIN
CNE100002995
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Fan Dong
Employee Count
-
Website
https://www.jafron.com
Ipo Date
2016-08-02
Details
Jafron Biomedical Co.,Ltd. engages in the research, development, production, and marketing of biological materials and medical devices in China. It offers solutions for kidney, liver, critical, and rheumatism diseases, as well as poisoning; adsorption products and blood purification machines; and other products, such as single use arteriovenous puncture, hemodialysis online dry powder bags/cylinders, disinfectants, hemodialysis concentrates, and medical adsorbable suture with needles. The company offers its products in Germany, Italy, Turkey, Thailand, Vietnam, the Philippines, South Africa, Kenya, Chile, Peru, and the United Arab Emirates. Jafron Biomedical Co.,Ltd. was founded in 1989 and is based in Zhuhai, China.